000			01297 a2200373 4500
005			20250512104357.0
264		0	_c19720403
008			197204s 0 0 ger d
022			_a0366-256X
040			_aNLM _beng _cNLM
100	1		_aVannotti, A
245	0	0	_a[Treatment of the porphyrias]. _h[electronic resource]
260			_bBibliotheca psychiatrica et neurologica _c1969
300			_a391-4 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenine Nucleotides _xtherapeutic use
650	0	4	_aBarbiturates _xadverse effects
650	0	4	_aCatalase _xtherapeutic use
650	0	4	_aCathartics _xtherapeutic use
650	0	4	_aChlorpromazine _xtherapeutic use
650	0	4	_aCholagogues and Choleretics _xtherapeutic use
650	0	4	_aConstipation _xetiology
650	0	4	_aDiet Therapy
650	0	4	_aDiuretics _xtherapeutic use
650	0	4	_aHistamine H1 Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLead Poisoning
650	0	4	_aNervous System Diseases _xetiology
650	0	4	_aPorphyrias _xchemically induced
650	0	4	_aPyridoxine _xtherapeutic use
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aVitamin B Complex _xtherapeutic use
773	0		_tBibliotheca psychiatrica et neurologica _gvol. 139 _gp. 391-4
999			_c4404911 _d4404911